Novonesis shareholding: BlackRock's stake rises to 5.01%
BlackRock's Novonesis shareholding reached 5.01% of share capital attached to shares on October 22, 2026, with aggregate holdings at 5.02%.
FINANCEVELIX / Charts
Stocks
NYSE / BLK
BlackRock, Inc. Common Stock · SEC CIK 2012383
Fiscal period: 2025-01-01 → 2025-12-31
| Fiscal period | Revenue | Net income | Operating cash flow |
|---|---|---|---|
| 2025-01-01 2025-12-31 | $24.22B | $5.55B | $3.93B |
| 2024-01-01 2024-12-31 | $12.79B | $6.37B | $4.96B |
| 2023-01-01 2023-12-31 | $11.01B | $5.5B | $4.17B |
Data checked:
Annual SEC filings; not the latest quarter or live prices. Balance-sheet values are at period end. A dash means unavailable, not zero. Accounting periods and industries differ. Each amount links to its filing.
Source: SEC XBRL · BlackRock, Inc.
Recent 10-K, 10-Q, 8-K, 20-F, 40-F and 6-K reports, including amendments. Up to 20 reports; checked every 15 minutes. Filing dates are not future earnings dates.
BlackRock, Inc. · NYSE:BLK · CIK 2012383
Data checked:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Report period:
Headlines are provided by TradingView. Full stories may open on the original publisher’s website.
Charts and market data by TradingView. Availability and delays vary by exchange.